Treatment of diabetes mellitus after renal transplantation

Newark, DE US
January 9, 2020

This presentation will discuss complications associated with kidney transplant that include transient post-transplant hyperglycemia and post-transplant diabetes mellitus in order to provide the pharmacist tools to distinguish and diagnose between the two. Pharmacists will receive in-depth pathophysiology of the kidney and its role in glucose homeostasis. Additionally, pharmacists will be able to recognize and analyze common immunosuppressants used in kidney transplant that may induce hyperglycemia (e.g., glucocorticoids, calcineurin inhibitors, etc). By the end of this presentation, pharmacists will be able to recommend pharmacologic treatment options that are patient-specific for the kidney transplant population.

Target Audience

  • Pharmacists

Learning Objectives

  1. Identify post-transplantation diabetes mellitus (PTDM)
  2. Analyze the role immunosuppressants play in contributing to PTDM
  3. Recommend pharmacologic treatment options for patients presenting with PTDM

Additional Information

AttachmentSize
Information for CE Credit - Treatment of diabetes mellitus.docx122.86 KB
Helpful Tips for Users.docx23.3 KB
Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
01/09/2020
Course expires: 
02/23/2020
Event starts: 
01/09/2020 - 12:00pm
Event ends: 
01/09/2020 - 1:00pm
Cost:
$0.00
Add to calendar: 
ChristianaCare Hospital
4755 Ogletown-Stanton Rd.
Newark, DE 19713
United States

Relevant financial relationships: Nadia Hellenga (planning committee member) received a speaker honorarium from Veloxis Pharmaceuticals

Planning committee members
Sean Lasota, PharmD, BCACP
Pharmacist
ChristianaCare Hospital
 
Nadia Hellenga, PharmD, BCPS
Pharmacist
ChristianaCare Hospital
 
Julie Dally, PharmD, BCPS, BCACP
Pharmacist
ChristianaCare Hospital
 
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
 
Presenter
Sumit Gandotra, PharmD
Pharmacist
ChristianaCare Hospital

Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare Hospital.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-021-L01-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.